Neuroprotection in multiple sclerosis: a therapeutic approach

Area of Science:

• Neuroscience
• Immunology
• Neurology

Background:

• Multiple sclerosis (MS) is a central nervous system demyelinating disease characterized by inflammation and neurodegeneration.
• Axonal damage and neuronal loss in MS begin early, potentially leading to irreversible disability.
• The molecular mechanisms driving neurodegeneration in MS are not fully understood, unlike inflammatory pathways.

Purpose of the Study:

• To review the current understanding of neurodegenerative processes in multiple sclerosis.
• To discuss potential outcome measures for neuroprotection trials in MS.
• To identify emerging therapeutic targets for neuroprotection in MS.

Main Methods:

• Literature review of neurodegenerative processes in multiple sclerosis.
• Analysis of current knowledge on molecular mechanisms of neurodegeneration in MS.
• Discussion of potential outcome measures and therapeutic targets for neuroprotection.

Main Results:

• Neurodegeneration is a significant component of MS pathology from disease onset.
• Understanding neurodegenerative mechanisms offers potential for novel neuroprotection strategies.
• Several potential therapeutic targets and outcome measures for neuroprotection trials are identified.

Conclusions:

• Neurodegeneration significantly contributes to disability progression in multiple sclerosis.
• Further research into MS neurodegeneration mechanisms is crucial for developing effective neuroprotective therapies.
• Identifying specific targets and outcome measures will advance clinical trials for neuroprotection in MS.